Available Biotechnology, Life Sciences, and Pharmaceutical FacilitiesUnderlining PharmaBioSource Realty services of facility transaction and disposition, asset management, equipment acquisition and disposition, and product exchange are the following core strengths:
Please find below a sampling of available Biotechnology, Life Sciences, and Pharmaceutical Facilities we either represent or have knowledge of. If any particular facility is of interest to you or maybe you have more specific needs, please don't hesitate to contact us at info@pharmabiosourcerealty.com or phone us at 610.293.0900. |
||
 |
||
| FACILITY TYPE | LOCATION | SITE DESCRIPTION |
| Biologics Manufacturing (click for website) |
Midwest US | 215,000 SF facility with 22,000L of mammalian cell culture capacity. |
| Liquids & Creams | Asia | Operating liquids and creams operation with contracts, facility and staff. |
| Generic Manufacturing | Europe | Operating generic manufacturer with a portfolio of products, facility and staff. |
| Parenteral Manufacturing | USA | Significant sterile operation with facility and staff. |
| Branded Generic Product Portfolio | Europe | Several small and medium size solid dosage products. |
| High Potency API Manufacturing Plant (click for website) |
Ireland | 350,000 SF high potency API manufacturing plant with containment capabilities for the manufacture of potent and cytotoxic compounds. |
API Manufacturing |
Asia | 40,000 SF operating API site with contracts, facility and staff. |
| Solid Dosage Manufacturing (click for website) |
Puerto Rico |  175,000 SF Solid dosage manufacturing operation. |
| Solid Dosage Manufacturing (click for brochure) |
Puerto Rico |  80,000 SF Solid dosage manufacturing facility. |
| Biologics Manufacturing | North America | cGMP biologics facility with contracts and staff. |
| Sterile Manufacturing Facility (click for press release) |
Southeast US |  47,000 SF sterile facility with associated lab and warehouse. |
| Parenteral Manufacturing | Southeast US | 50,000+ SF cGMP facility with over 500 SF of Lyophilization capacity. |
| Biologics Manufacturing | West Coast US | 60,000+ SF cGMP facility for bulk biologic API. |
| Parenteral Manufacturing (click for press release) |
Midwest US | King Pharmaceuticals Parenteral manufacturing business with 12 branded generic hospital products. |
| Biologics Manufacturing (click for website) |
Northeast US | 50,000+ SF stand alone, GMP plant with preclinical, Phase I and Phase II capability to 2000L. |
| API Manufacturing & Dosage Form (click for website) |
UK | 500,000 SF multi-product, multi-use development and manufacturing campus with staff and contracts. |
| Biologics Manufacturing | Europe | cGMP biologics facility with contracts and staff. |
| R&D / Manufacturing | Sweden | Over 2,000,000 SF of state-of-the-art facilities. |
| Biologics R&D Facility | Northeast US |  44,000 SF state-of-the-art biologics R&D facility. |
| Chemical Manufacturing | Southeast US | Significant API site available as ongoing concern with staff and some contracts. |
| Parenteral Manufacturing | Eastern Europe | 127,000 SF parenteral and semi-solids manufacturing facility with staff and some contracts. |
| Manufacturing | Singapore | 200,000 SF multi-use facility complete with equipment. |
| Sterile Manufacturing | Mid-Atlantic | 25,000 SF ophthalmics manufacturing facility with equipment as well as some staff and contract opportunities. |
| Sterile Manufacturing | Southeast US | 60,000 SF parenteral manufacturing facility with equipment. |
| R&D Campus | Europe | 300,000 SF clinical trial, R&D and pilot facilities for small molecule drug development and launch. The site is staffed and a contract is available. |
| Parenteral Manufacturing | Puerto Rico | 200,000 SF operating sterile (parenteral) facility with operations being phased out and some staff may be available. |
| API Manufacturing | Southeast US | 500,000 SF on over 1,000 acres with three API plants with operations being phased out. Some staff and contracts may be available. |
| R&D | Northeast US | 130,000 SF research lab facility built in 1992 with multi-function Pilot Plant with expansion capability on 17 acres. |
| R&D | Northeast US | 200,000 SF research laboratories with zoning for vivarium addition. |
| Parenteral Manufacturing | Puerto Rico | 150,000+ SF operating sterile (parenteral) facility with some staff available as operations being phased out. |
| Manufacturing | Mid-Atlantic US | 200,000 SF multi-product, multi-use pharmaceutical manufacturing facility with significant amount of equipment available. |
| Biologics Facility | Northeast US | 70,000+ former E-coli manufacturing operation. |
| Parenteral Manufacturing | Northeast US | 70,000+ SF cGMP facility phasing out operations possibly with some staff and contracts available. |
| R&D | Northeast US | Over 200,000 SF laboratory, R&D space - 90 acre campus. |
| Manufacturing | Midwest US | 269,000 SF multi-purpose facility with 7 clean rooms totaling 71,000 SF available for lease. |
| Parenteral Manufacturing | Northeast US |  200,000 SF multi-product manufacturing facility. Available with equipment, staff and some contracts. |
| Parenteral Manufacturing | Puerto Rico | Significant operating parenteral operation with lyophilization, contracts and staff. |
| Solids Manufacturing | Puerto Rico | Significant state of the art solids operation with contracts and staff. |
| Parenteral Manufacturing | Mid-Atlantic | Parenteral CRO/CMO with contracts and staff. |
For questions or inquiries regarding this list of available Biotechnology, Life Sciences, and Pharmaceutical Facilities or others of which we may be aware, please contact us at info@pharmabiosourcerealty.com or phone us at 610.293.0900. |
||
|
PharmaBioSource, Inc., 121 West Wayne Avenue, Wayne, PA 19087 • Phone: 610.293.0900 • Fax: 610.293.6907
|
© Copyright 2009 PharmaBioSource, Inc. All rights reserved.